InPharmX Inc., DBA University Learning Systems Phone: 1-800-940-5860 Email: info@universitylearning.com
Professional learning online at a desk
← All on demand pharmacology CE/CME

On demand pharmacology CE/CME

Cardiovascular Pharmacotherapy Update - Lake Placid

FormatSelf-paced onlineRecordedJune 25, 2025AccessAvailable now
Log in to register

About this course

Learn at your own pace.

  • Recorded live in Lake Placid in June 25-26 2025.

  • Provides 15 Hours of ACPE Home Study credit.

  • Valid through June 26, 2028

Educational information

Designed for meaningful, practical learning.

Sessions

Session
2025-06-25 Don’t Skip a Beat… Cardiovascular Pharmacotherapy Update Part 1: CV Risk Estimation, Hypertension, and Obesity

Wednesday, June 25, 2025

Speaker: Dr. Joseph Saseen Credit hours: 5 ACPE UAN: 0741-0000-25-016-H01-P

Learning objectives
  1. Explain recommendations from the American College of Cardiology/American Heart Association guidelines for treatment of patients with hypertension
  2. Review lifestyle modifications that are recommended for the treatment and prevention of cardiovascular disease
  3. Summarize how future cardiovascular risk is estimated in primary prevention patients using the Pooled Cohort Equations and PREVENT calculator
  4. Formulate a care plan for patients with resistant hypertension based on the 2018 American Heart Association scientific statement
  5. Describe emerging pharmacotherapies for the treatment of hypertension
  6. List guideline recommendations supporting the use of antiplatelet therapy for primary prevention patients
  7. Examine the evidence-based CV risk reduction benefits of medications used to treat overweight and obese patients
  8. Create treatment plans that reduce the risk cardiovascular disease
2025-06-26 Don’t Skip a Beat Cardiovascular Pharmacotherapy Update Part 2: Dyslipidemia, Chronic Coronary Disease and Peripheral Arterial Disease

Thursday, June 26, 2025

Speaker: Dr. Joseph Saseen Credit hours: 5 ACPE UAN: 0741-0000-25-017-H01-P

Learning objectives
  1. Explain recommendations from the American College of Cardiology/American Heart Association guidelines for treatment of patients with hypercholesterolemia, chronic coronary disease, and peripheral arterial disease
  2. Apply the treatment approaches recommended in the 2018 ACC-AHA cholesterol guideline to patients with hypercholesterolemia
  3. Interpret recommendations from the ACC Expert Consensus Decision Pathway for non-statins and treatment of hypertriglyceridemia
  4. Define the evidence and role in therapy of nonstatin medications in the treatment of hypercholesterolemia
  5. Describe the evidence and guideline recommendations supporting the use of antiplatelet and antithrombotic therapy for secondary prevention patients
  6. List evidence-based drug therapy recommendations for the management of patients with chronic coronary disease and peripheral arterial disease
  7. Evaluate the role of colchicine in the prevention of CV events
  8. Create treatment plans that reduce the risk of cardiovascular disease
2025-06-27 Don’t Skip a Beat… Cardiovascular Pharmacotherapy Update Part 3: Heart Failure, Atrial Fibrillation, and Promoting Health Equity

Friday, June 27, 2025

Speaker: Dr. Joseph Saseen Credit hours: 5 ACPE UAN: 0741-0000-25-018-H01-P

Learning objectives
  1. Explain recommendations from the American College of Cardiology/American Heart Association guidelines for treatment of patients with heart failure with reduced ejection fraction, heart failure with preserved ejection fraction, and atrial fibrillation.
  2. Describe the pillars of therapy for heart failure.
  3. Examine results from cardiovascular outcome trials evaluating the use of angiotensin–neprilysin inhibition in heart failure with reduce ejection fraction.
  4. Examine results from cardiovascular outcome trials evaluating the use of SGLT2 inhibitors in heart failure.
  5. Discuss pharmacotherapy used for reducing the risk of stroke and rate and rhythm control in atrial fibrillation.
  6. Recall strategies to promote health equity in cardiovascular disease management..
  7. Create treatment plans that reduce the risk of cardiovascular disease . stroke and rate and rhythm control in atrial fibrillation.

Faculty

Portrait of Dr. Joseph Saseen, ULS faculty member

Dr. Joseph Saseen, PharmD, FASHP, FCCP, BCPS, BCACP

Associate Dean for Clinical Affairs and Professor · University of Colorado Skaggs School of Pharmacy

A nationally recognized ambulatory-care and cardiovascular-risk-reduction educator with nearly 200 peer-reviewed publications and book chapters.

Professional profile ↗

Accreditation

Target audience

Pharmacists, Nurse Practitioners, Physicians, Physician Assistants, Nurses

PHARMACISTS

  • University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. 
  • These programs are accredited for all pharmacists.
  • This course provides 15 hours or 1.5 CEUs.
  • Credit for this course expires on June 25, 2028.

NURSES

  • This course provides 15 hours (1.5 CEU)
  • University Learning Systems is approved by the California Board of Registered Nursing, Provider Number CEP 11409, and CE Broker Tracking #50-11357:
  • University Learning Systems is approved by CE Broker for Florida, Georgia, Arkansas, District of Columbia, Georgia, New Mexico, and West Virginia, Boards of Nursing. 
  • The same hours submitted to renew NP certification may be submitted to a State Board of Nursing for re-licensure.

OTHER PROFESSIONS

  • CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.

  • CANADIAN PHARMACISTS:Canadian Council on Continuing Education in Pharmacy (CCCEP)accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). 

  • CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians

  • Other healthcare professionals should confirm acceptance and reporting requirements with their licensing or certification board

Requirements and reporting

  • University Learning Systems reports pharmacy credit through CPE Monitor using the participant’s eNABPID number and date of birth.
  • University Learning Systems is approved by CE Broker, for pharmacy, medicine and nursing for participating states,  Tracking #50-11357. Participant's state license number is required for reporting.
  • Credit is based on completed evaluations for registered sessions. 
  • Credit is awarded per session; partial session credit is not available, and breaks are excluded.
  • Other eligible participants receive an applicable statement of credit after completing the required documentation.

Review complete ULS accreditation statements →

Course fees

DescriptionPrice
Default 15 Hours$250

Begin today

Ready when you are.

Log in to register